---
title: "Mibefradil - Angina pectoris"
sidebar: mydoc_sidebar
permalink: db01388-mesh-d000787-1.html
toc: false 
---


Path ID: `DB01388_MESH_D000787_1`
{% include image.html url="images/db01388-mesh-d000787-1.png" file="db01388-mesh-d000787-1.png" alt="db01388-mesh-d000787-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D020748 | mibefradil | Drug |
| UniProt:O43497 | Voltage-dependent T-type calcium channel subunit alpha-1G | Protein |
| UniProt:Q13936 | Voltage-dependent L-type calcium channel subunit alpha-1C | Protein |
| UniProt:O95180 | Voltage-dependent T-type calcium channel subunit alpha-1H | Protein |
| UniProt:Q01668 | Voltage-dependent L-type calcium channel subunit alpha-1D | Protein |
| UniProt:O60840 | Voltage-dependent L-type calcium channel subunit alpha-1F | Protein |
| UniProt:Q9P0X4 | Voltage-dependent T-type calcium channel subunit alpha-1I | Protein |
| UniProt:Q13698 | Voltage-dependent L-type calcium channel subunit alpha-1S | Protein |
| GO:0070509 | transmembrane calcium influx | BiologicalProcess |
| GO:0045907 | positive regulation of vasoconstriction | BiologicalProcess |
| GO:0008015 | blood circulation | BiologicalProcess |
| MESH:D000787 | Angina pectoris | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Mibefradil | DECREASES ACTIVITY OF | Voltage-Dependent T-Type Calcium Channel Subunit Alpha-1G |
| Mibefradil | DECREASES ACTIVITY OF | Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1C |
| Mibefradil | DECREASES ACTIVITY OF | Voltage-Dependent T-Type Calcium Channel Subunit Alpha-1H |
| Mibefradil | DECREASES ACTIVITY OF | Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1D |
| Mibefradil | DECREASES ACTIVITY OF | Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1F |
| Mibefradil | DECREASES ACTIVITY OF | Voltage-Dependent T-Type Calcium Channel Subunit Alpha-1I |
| Mibefradil | DECREASES ACTIVITY OF | Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1S |
| Voltage-Dependent T-Type Calcium Channel Subunit Alpha-1G | PARTICIPATES IN | Transmembrane Calcium Influx |
| Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1C | PARTICIPATES IN | Transmembrane Calcium Influx |
| Voltage-Dependent T-Type Calcium Channel Subunit Alpha-1H | PARTICIPATES IN | Transmembrane Calcium Influx |
| Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1D | PARTICIPATES IN | Transmembrane Calcium Influx |
| Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1F | PARTICIPATES IN | Transmembrane Calcium Influx |
| Voltage-Dependent T-Type Calcium Channel Subunit Alpha-1I | PARTICIPATES IN | Transmembrane Calcium Influx |
| Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1S | PARTICIPATES IN | Transmembrane Calcium Influx |
| Transmembrane Calcium Influx | CONTRIBUTES TO | Positive Regulation Of Vasoconstriction |
| Positive Regulation Of Vasoconstriction | NEGATIVELY REGULATES | Blood Circulation |
| Blood Circulation | NEGATIVELY CORRELATED WITH | Angina Pectoris |
|---------|-----------|---------|

Comment: Mibefradil was withdrawn from the market in 1998 because of potentially harmful interactions with other drugs

Reference: [https://go.drugbank.com/drugs/DB01388#mechanism-of-action](https://go.drugbank.com/drugs/DB01388#mechanism-of-action){:target="_blank"}